Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Stephen W Shanks, DO
Family Practice · SHIPROCK, NM · NPI 1114346129
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 642 | 97 |
| Levothyroxine Sodium | Levothyroxine Sodium | 626 | 62 |
| Atorvastatin Calcium | Atorvastatin Calcium | 562 | 87 |
| Furosemide | Furosemide | 413 | 69 |
| Metformin Hcl | Metformin Hcl | 297 | 50 |
| Tamsulosin Hcl | Tamsulosin Hcl | 296 | 32 |
| Levetiracetam | Levetiracetam | 266 | 24 |
| Lisinopril | Lisinopril | 264 | 54 |
| Sertraline Hcl | Sertraline Hcl | 264 | 29 |
| Trazodone Hcl | Trazodone Hcl | 259 | 31 |
| Amlodipine Besylate | Amlodipine Besylate | 253 | 50 |
| Pantoprazole Sodium | Pantoprazole Sodium | 248 | 30 |
| Eliquis | Apixaban | 219 | 22 |
| Losartan Potassium | Losartan Potassium | 213 | 31 |
| Mirtazapine | Mirtazapine | 204 | 34 |
| Quetiapine Fumarate | Quetiapine Fumarate | 201 | 26 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 179 | 22 |
| Potassium Chloride | Potassium Chloride | 167 | 34 |
| Clopidogrel | Clopidogrel Bisulfate | 165 | 38 |
| Divalproex Sodium | Divalproex Sodium | 161 | 13 |
| Finasteride | Finasteride | 129 | 12 |
| Donepezil Hcl | Donepezil Hcl | 127 | 17 |
| Metoprolol Tartrate | Metoprolol Tartrate | 125 | 21 |
| Fluoxetine Hcl | Fluoxetine Hcl | 118 | 16 |
| Memantine Hcl | Memantine Hcl | 114 | 18 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 112 | 11 |
| Carvedilol | Carvedilol | 112 | 16 |
| Latanoprost | Latanoprost | 102 | 14 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 101 | 25 |
| Citalopram Hbr | Citalopram Hydrobromide | 100 | 16 |
| Escitalopram Oxalate | Escitalopram Oxalate | 100 | 17 |
| Ondansetron Hcl | Ondansetron Hcl | 100 | 52 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 95 | 19 |
| Simvastatin | Simvastatin | 95 | 13 |
| Jardiance | Empagliflozin | 93 | 20 |
| Lactulose | Lactulose | 88 | 13 |
| Midodrine Hcl | Midodrine Hcl | 85 | 12 |
| Cephalexin | Cephalexin | 81 | 31 |
| Paroxetine Hcl | Paroxetine Hcl | 80 | 14 |
| Baclofen | Baclofen | 78 | 11 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 78 | 12 |
| Tramadol Hcl | Tramadol Hcl | 76 | 33 |
| Metoprolol Succinate | Metoprolol Succinate | 74 | 20 |
| Buspirone Hcl | Buspirone Hcl | 71 | suppressed |
| Hydrocortisone | Hydrocortisone | 69 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 69 | 21 |
| Lorazepam | Lorazepam | 69 | 39 |
| Nifedipine Er | Nifedipine | 68 | 11 |
| Alendronate Sodium | Alendronate Sodium | 67 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 66 | 19 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 64 | 16 |
| Oxybutynin Chloride | Oxybutynin Chloride | 62 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 61 | 11 |
| Myrbetriq | Mirabegron | 60 | suppressed |
| Spironolactone | Spironolactone | 58 | suppressed |
| Olanzapine | Olanzapine | 57 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 56 | 24 |
| Insulin Aspart Flexpen | Insulin Aspart | 55 | 17 |
| Bupropion Xl | Bupropion Hcl | 49 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 48 | 12 |
| Rexulti | Brexpiprazole | 47 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 45 | 12 |
| Lamotrigine | Lamotrigine | 45 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 44 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 43 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 40 | 13 |
| Xifaxan | Rifaximin | 40 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 39 | 11 |
| Nystatin | Nystatin | 39 | 23 |
| Pregabalin | Pregabalin | 39 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 38 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 38 | 11 |
| Sucralfate | Sucralfate | 38 | suppressed |
| Glipizide | Glipizide | 37 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 37 | 32 |
| Xarelto | Rivaroxaban | 36 | suppressed |
| Glipizide Er | Glipizide | 35 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 35 | 13 |
| Novolog Flexpen | Insulin Aspart | 35 | suppressed |
| Omeprazole | Omeprazole | 35 | suppressed |
| Risperidone | Risperidone | 35 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 34 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 30 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 30 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 28 | 15 |
| Fluconazole | Fluconazole | 28 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 28 | suppressed |
| Ketoconazole | Ketoconazole | 28 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 28 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 16 |
| Aripiprazole | Aripiprazole | 27 | suppressed |
| Lacosamide | Lacosamide | 27 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 26 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 26 | suppressed |
| Gemtesa | Vibegron | 26 | suppressed |
| Levetiracetam Er | Levetiracetam | 26 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 25 | suppressed |
| Dantrolene Sodium | Dantrolene Sodium | 24 | suppressed |
| Meloxicam | Meloxicam | 24 | suppressed |
| Bicalutamide | Bicalutamide | 23 | suppressed |
| Enulose | Lactulose | 23 | suppressed |
| Nystop | Nystatin | 23 | 12 |
| Ofloxacin | Ofloxacin | 23 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 16 |
| Alphagan P | Brimonidine Tartrate | 21 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 21 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 21 | suppressed |
| Brilinta | Ticagrelor | 20 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 20 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 15 |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Phenytoin | Phenytoin | 19 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 19 | suppressed |
| Timolol Maleate | Timolol Maleate | 19 | suppressed |
| Ozempic | Semaglutide | 18 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 17 | 17 |
| Atenolol | Atenolol | 17 | suppressed |
| Erythromycin | Erythromycin Base | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Naproxen | Naproxen | 17 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 16 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 16 | suppressed |
| Prednisone | Prednisone | 16 | 13 |
| Tradjenta | Linagliptin | 16 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 16 | suppressed |
| Calcium Acetate | Calcium Acetate | 15 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 15 | suppressed |
| Entresto | Sacubitril/Valsartan | 15 | suppressed |
| Famotidine | Famotidine | 15 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 15 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 14 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Irbesartan | Irbesartan | 14 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 14 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 13 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 13 | suppressed |
| Januvia | Sitagliptin Phosphate | 13 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 13 | suppressed |
| Trulicity | Dulaglutide | 13 | suppressed |
| Allopurinol | Allopurinol | 12 | suppressed |
| Alogliptin | Alogliptin Benzoate | 12 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 12 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 12 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 11 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Ezetimibe | Ezetimibe | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Quinidine Sulfate | Quinidine Sulfate | 11 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error